472 related articles for article (PubMed ID: 9251592)
1. Association between leprosy and HIV infection in Tanzania.
van den Broek J; Chum HJ; Swai R; O'Brien RJ
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):203-10. PubMed ID: 9251592
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 infection as a risk factor for leprosy; a case-control study in Tanzania.
Borgdorff MW; van den Broek J; Chum HJ; Klokke AH; Graf P; Barongo LR; Newell JN
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):556-62. PubMed ID: 8151186
[TBL] [Abstract][Full Text] [Related]
3. Effect of HIV infection on leprosy: a three-year survey in Bamako, Mali.
Lienhardt C; Kamate B; Jamet P; Tounkara A; Faye OC; Sow SO; Bobin P
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):383-91. PubMed ID: 9030103
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of HIV1 in leprosy patients in Rio de Janeiro, Brazil.
Andrade VL; Moreira Alves T; Regazzi Avelleira JC; Bayona M
Acta Leprol; 1997; 10(3):159-63. PubMed ID: 9259886
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safety.
McFarland W; Mvere D; Katzenstein D
AIDS; 1997 Sep; 11 Suppl 1():S97-102. PubMed ID: 9376107
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India.
Zodpey SP; Ambadekar NN; Thakur A
Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132
[TBL] [Abstract][Full Text] [Related]
7. Sentinel surveillance for HIV-1 infection: how representative are blood donors, outpatients with fever, anaemia, or sexually transmitted diseases, and antenatal clinic attenders in Mwanza Region, Tanzania?
Borgdorff M; Barongo L; van Jaarsveld E; Klokke A; Senkoro K; Newell J; Nicoll A; Mosha F; Grosskurth H; Swai R
AIDS; 1993 Apr; 7(4):567-72. PubMed ID: 8507421
[TBL] [Abstract][Full Text] [Related]
8. Sentinel surveillance and cross sectional survey on HIV infection prevalence: a comparative study.
Kwesigabo G; Killewo JZ; Sandstrom A
East Afr Med J; 1996 May; 73(5):298-302. PubMed ID: 8756031
[TBL] [Abstract][Full Text] [Related]
9. Trend in HIV prevalence among tuberculosis patients in Tanzania, 1991-1998.
Range N; Ipuge YA; O'Brien RJ; Egwaga SM; Mfinanga SG; Chonde TM; Mukadi YD; Borgdorff MW
Int J Tuberc Lung Dis; 2001 May; 5(5):405-12. PubMed ID: 11336270
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of HIV infection and high-risk characteristics among leprosy patients of south India; a case-control study.
Sekar B; Jayasheela M; Chattopadhya D; Anandan D; Rathinavel L; Vasanthi B; Subramanian M; Rao PS
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):527-31. PubMed ID: 7868949
[TBL] [Abstract][Full Text] [Related]
11. Case-control study of BCG vaccination as a risk factor for leprosy and tuberculosis in western Kenya.
Orege PA; Fine PE; Lucas SB; Obura M; Okelo C; Okuku P
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):542-9. PubMed ID: 8151184
[TBL] [Abstract][Full Text] [Related]
12. BCG vaccination protects against leprosy in Venezuela: a case-control study.
Convit J; Smith PG; Zuniga M; Sampson C; Ulrich M; Plata JA; Silva J; Molina J; Salgado A
Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):185-91. PubMed ID: 8371026
[TBL] [Abstract][Full Text] [Related]
13. Is HIV infection a risk factor for leprosy?
Pönnighaus JM; Mwanjasi LJ; Fine PE; Shaw MA; Turner AC; Oxborrow SM; Lucas SB; Jenkins PA; Sterne JA; Bliss L
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):221-8. PubMed ID: 2071978
[TBL] [Abstract][Full Text] [Related]
14. The impact of the HIV epidemic on tuberculosis transmission in Tanzania.
Egwaga SM; Cobelens FG; Muwinge H; Verhage C; Kalisvaart N; Borgdorff MW
AIDS; 2006 Apr; 20(6):915-21. PubMed ID: 16549977
[TBL] [Abstract][Full Text] [Related]
15. Clinico-epidemiological patterns of HIV infection in STD patients in Ibadan.
Ekweozor CC; Olaleye OD; Tomori O; Saliu I; Essien EM; Bakare RA; Oni AA; Oyewo OO; Okesola AO; Onyemenem TN
Afr J Med Med Sci; 1995 Dec; 24(4):321-7. PubMed ID: 8886145
[TBL] [Abstract][Full Text] [Related]
16. Protective efficacy of BCG against leprosy in São Paulo.
Lombardi C; Pedrazzani ES; Pedrazzani JC; Filho PF; Zicker F
Bull Pan Am Health Organ; 1996 Mar; 30(1):24-30. PubMed ID: 8919722
[TBL] [Abstract][Full Text] [Related]
17. Leprosy and infection with the human immunodeficiency virus in Uganda; a case-control study.
Kawuma HJ; Bwire R; Adatu-Engwau F
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):521-6. PubMed ID: 7868948
[TBL] [Abstract][Full Text] [Related]
18. HIV sero-prevalence among tuberculosis patients in Kenya.
Van Gorkom J; Kibuga D; Adallah S; Adungosi J; Aluvaala B; Kangangi J; Kutwa A; Olewe M; Rono P; Wambua M
East Afr Med J; 1999 Aug; 76(8):452-6. PubMed ID: 10520351
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of bacillus Calmette-Guerin (BCG) vaccination in the prevention of leprosy; a case-finding control study in Nagpur, India.
Zodpey SP; Shrikhande SN; Salodkar AD; Maldhure BR; Kulkarni SW
Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):309-15. PubMed ID: 9934357
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for human immunodeficiency virus infection among blood donors in Sao Paulo, Brazil, and their relevance to current donor deferral criteria.
de Almeida Neto C; McFarland W; Murphy EL; Chen S; Nogueira FA; Mendrone A; Salles NA; Chamone DA; Sabino EC
Transfusion; 2007 Apr; 47(4):608-14. PubMed ID: 17381618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
